Softbank China Venture Capital
China autonomous truck developer DeepWay raises $112m
China’s DeepWay, a smart electric truck developer established by Baidu, has raised CNY 770m (USD 112m) in an extended Series A round featuring SB China Venture Capital (SBCVC).
Primavera joins $326m round for Taiwan EV supplier
Primavera Capital Group has made its second cleantech investment in a matter of days, with participation in a $326 million round for Taiwan-based battery manufacturer ProLogium Technology.
China autonomous sanitation vehicle maker raises $250m
CowaRobot, a Chinese autonomous driving technology developer with an initial focus on sanitation vehicles, has raised $250 million in Series C funding.
China online pharmacy Dingdang seeks Hong Kong IPO
Dingdang Health, a Chinese online pharmacy business that raised $220 million in funding earlier this month, has filed for a Hong Kong IPO.
Temasek leads round for China marketing content start-up
Tezign, a Chinese start-up that serves as a content-focused one-stop marketing solutions platform, has closed a second tranche of Series C funding that takes the overall total for the round to $100 million.
China cancer screening business gains on Hong Kong debut
New Horizon Health, a China-based and venture capital-backed cancer early screening company, rose 215% on its trading debut following a HK$2 billion ($258 million) Hong Kong IPO.
Tencent backs Chinese healthcare cloud services platform
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Chinese expense management specialist secures $42m
China Renaissance has led a RMB300 million ($42 million) extended Series C round for Chinese expense management solution provider Huilianyi. Additional contributions came from existing investors SBCVC, Blue Lake Capital and Z Capital.
Chinese genetic testing player secures $115m round
Geneseeq, a Chinese genetic testing company that focuses on treatments for cancer, has raised RMB800 million ($115 million) in a funding round led by state-owned China Reform Holding Corporation.
Chinese healthcare software provider raises $212m
Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs) has raised RMB1.5 billion ($212 million) through an extended Series E round of funding.
VCs to exit China job site as Meitu buys majority stake
Northern Light Venture Capital (NLVC), SBCVC and Hotung Venture Group will exit Chinese online recruitment platform Dajie.com after Meitu agreed to buy a majority stake in the business. The valuation of $88.4 million represents a small premium to the...
China's New Horizon Health raises $66m Series C
China-based New Horizon Health, which produces home cancer test kits, has raised $66 million in a Series C round of funding led by VMS Group, a Hong Kong-based investment firm.
Softbank leads $89m round for Chinese online drug retailer
China-based Dingdang Kuaiyao, an online-to-offline (O2O) medicine retailer, has raised RMB600 million ($89 million) in a new round of funding led by existing investor Softbank China Venture Capital.
TPG-SoftBank fund backs Chinese restaurant services platform
Shiheng Technology, a Chinese company that helps restaurants manage their online food delivery businesses, has completed the second tranche of a Series B round led by a TPG Capital and SoftBank Ventures Korea fund.
San Francisco pension fund backs China's SBCVC - update
San Francisco City & County Employees’ Retirement System has committed $25 million to SBCVC’s sixth China fund, which has a target of $500 million. The GP closed its previous VC vehicle at $459 million in 2016.
Chinese healthcare SaaS platform raises $48m
Taimei Medical Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs), has raised RMB300 million ($48 million) in Series D funding.
VCs invest $32m in China's HaploX Biotechnology
A group of investors including SBCVC and Kexin Capital have backed a $32 million funding round for China’s HaploX Biotechnology.
SBCVC leads $30m round for China healthcare AI firm
SBCVC has led a RMB200 million ($30 million) Series B round for 12 Sigma, a China-based biotechnology company that applies artificial intelligence (AI) technology to medical image diagnoses.
SBCVC leads $33m round for China’s Malong Technologies
SBCVC has led a RMB220 million ($33 million) Series B round for Shenzhen-based Malong Technologies – its first investment in an artificial intelligence (AI) technology company in China.
China genomics player Annoroad raises $105m Series C
Beijing-based genomics services provider Annoroad has completed a RMB700 million ($105 million) Series C round co-led by Shenzhen GTJA Investment Group and Ping An Ventures. SBCVC and SAIF Partners China also participated.
Chinese medical device company Ankon raises $100m
Shanghai-based Ankon Medical Technologies, which develops medical equipment for gastric examination, has raised a $100 million round of funding from investors including SBCVC.
Qiming leads $20m round for China cancer specialist
Qiming Venture Partners has led a $20 million round for New Horizon Health, a Chinese start-up that develops cancer screening technology, with participation from existing investors Legend Capital and SBCVC.
China VC-backed robotics start-up CloudMinds raises $100m
CloudMinds, a Chinese cloud-based robotics start-up backed by several VC investors, has closed a $100 million Series A round of funding from a group of investors.